RoukenBio & Avs Bio  300 x 75 white

Biologics Symposium 2027 – Swiss edition

 From Biologic to Investment: What Investors Want to See 

Location: MC3 Main Campus - Allschwil
  Date: 21 January 2027
 
Free to attend*

Agenda Coming Soon...

Confirmed speakers

Hear from industry experts.

Christian Klein

Christian Klein

CSO, Biotech Start Up
Ilse AVS Bio

Ilse Roodink

VP of Scientific Innovation, AVS Bio
Emilio Cosimo Director of Inovation RoukenBio

Emilio Cosimo

Director of Innovation, RoukenBio
Marcela Guzman molecularpartners

Marcela Guzman Ayala

Senior Director of Research, Molecular Partners
Alberto Toso alentis

Alberto Toso

CSO, Alentis Therapeutics
Stefan Scherer

Stefan Scherer

CEO, 3T Biosciences

About the Swiss Symposium 2027



Advanced biologics are reshaping therapeutic innovation, combining engineered proteins, antibodies, and cellular approaches to target disease with exceptional precision.

The Basel region is one of the world's leading life science and biopharma hubs, bringing together pioneering biotechnology companies, global pharmaceutical innovators and cutting-edge research institutions, making it the ideal setting to exchange ideas and explore the future of biologics discovery and development.

Together we will explore:

•    Early characterization strategies that reduce downstream surprises
•    Innovative biologics platforms for oncology and beyond
•    Emerging targets and new mechanism of action
•    Novel antibody formats and functional profiling of mono-  and multi-specific antibodies 

Come for the insights and stay for the conversations that move programs forward.

Basel Swiss Symposium 2027 by RoukenBio and AVS Bio

Experience the atmosphere


Take a look at some of the standout moments from our 2026 Dutch Biologics Symposium.

 

Insightful conversations
Engaging talks and data
Networking opportunities

How to get to the venue 

Getting to MC3 Main Campus Convention Centre

Address: Hegenheimermattweg 167D, 4123 Allschwil, Switzerland

  • By train: From Basel SBB Railway Station, take Tram Line 6 towards Allschwil. Alight at either: Allschwil, Gartenstrasse or Allschwil, Ziegelei. From both stops, the venue is a short walk away through the Switzerland Innovation Park Basel Area.
  • By bus: Several local bus services connect Basel city centre and the surrounding area to Allschwil. Travel to a stop serving the Switzerland Innovation Park Basel Area, then follow signs to Hegenheimermattweg 167D.
  • By car: The venue is easily accessible via the A35/A3 motorway network. Follow signs for Allschwil and take the Allschwil motorway exit. Continue to Hegenheimermattweg 167D. On-site parking is available, and additional parking facilities are located within the campus area.

About the organisers

Antibody Analytics - The Creative Collaborative Consultative Immunology CRO - 01

RoukenBio - Immunology CRO redefined is providing discovery to IND-enabling immunology and bioassay research services to a global customer base in the therapeutic areas of inflammation, auto-immunity, immuno-oncology, oncology and beyond. Our vision is to become the most trusted research partner for biotherapeutic innovators.

Backed by our brilliant minds, we have turned the traditional CRO model on its head by fostering a collaborative and personalised approach.

Our mission is simple: Solve problems. Deliver quality data. Propel your drug discovery breakthroughs.

avsbio-logo=royal-blue


AVS Bio
is a global company supporting the development of biologics for animal and human health with products and services at its operational sites in North America and Europe.

AVS Bio offers design-driven antibody discovery and development services, tailored to target insights and lead antibody requirements. Since 2018, AVS Bio has supported more than 100 life sciences companies launch successful lead antibody programs, including the development of 10 antibodies that entered clinical trials.

AVS Bio completed over 3,250 standalone protein production and purification programs over the past decades.

Our clients trust us for our expertise, efficiency, and commitment to turning complex challenges into successful outcomes.

* Registration is open exclusively to therapeutic developers and academics. If you do not fall into these categories, please email hello@rouken.bio to request permission to attend.